Results 121 to 130 of about 17,943 (173)

Low dose of sugammadex versus neostigmine for reversal of rocuronium induced moderate neuromuscular block: a randomized controlled trial. [PDF]

BMC Anesthesiol
Hadj-Mimoune S, Morisson L, Ellassraoui S, Idrissi M, Quach M, Godin N, Oulehri W, Fortier LP, Verdonck O, Laferrière-Langlois P, Richebé P.   +10 more
europepmc   +1 more source

Rocuronium-Induced Rhabdomyolysis: A Case Report and Literature Review. [PDF]

Cureus
Liang M, Ji Z, Tang J, Hu Y, Nie G.
europepmc   +1 more source

Dose-Response Evaluation of Sugammadex for Reversal of Deep Rocuronium-Induced Neuromuscular Block in Cats. [PDF]

Vet Sci
Cesnik NM, D'Angelo Campos K, Cavaco JS, Navarro CS, Holanda AGA, Matera JM, Ambrósio AM.   +6 more
europepmc   +1 more source

Inhaled nitric oxide stabilizes acute right ventricular failure due to hypercapnia in abdominal compartment syndrome: a case report. [PDF]

JA Clin Rep
Takei Y, Sato Y, Saito H, Nishimaki H, Tanaka S, Toyama H, Ejima Y, Yamauchi M.   +7 more
europepmc   +1 more source

Author's comments on RECAP-MEP trial. [PDF]

Surg Neurol Int
Suresh S, Hrishi AP, Thiruvathra J, Divakar G.   +3 more
europepmc   +1 more source

Effect of lidocaine and magnesium sulfate on rocuronium onset time: a randomized controlled experimental study. [PDF]

Braz J Anesthesiol
Cocenza Varrichio Crispim M, Otsuki DA, Vicentini YF, Rodrigues DRP, Egúsquiza MGP, Junior JOCA.   +5 more
europepmc   +1 more source

Comprehensive Study of Drug-Associated Severe Allergic Reactions: An Analysis of High-Risk Medications and Epidemiological Trends Based on the FAERS Database. [PDF]

Allergy Asthma Immunol Res
Mo W, Ouyang M, Yang H, Kong W.
europepmc   +1 more source

Remimazolam for hemodynamic stabilization in patients with perioperative arrhythmia: report of two cases. [PDF]

Am J Transl Res
Kim HT, Lee JY.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Rocuronium and malignant hyperthermia

American Journal of Health-System Pharmacy, 2012
Beggs et al.[1][1] presented two interesting case reports postulating an association between rocuronium and malignant hyperthermia (MH). Although the observed fever in these patients declined after discontinuation of rocuronium, several points need further discussion.
Frank, Schuster, Stephan, Johannsen
openaire   +2 more sources

[Rocuronium].

Revista espanola de anestesiologia y reanimacion, 1998
Rocuronium is a new nondepolarizing neuromuscular blocking agent (NDNMBA) that has recently been introduced for clinical use. Its main advantage over other such agents is its rapid onset of action, which may lead to its use as the relaxant of choice when rapid intubation is required. An additional advantage is that, unlike other amino-steroidal NDNMBAs,
openaire   +1 more source